Your prediction
Novozymes A/S B Stock
The Novozymes A/S B stock is trending slightly upwards today, with an increase of €0.080 (0.140%) compared to yesterday's price.
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | 0.140% | -1.660% | -2.281% | -1.764% | 1.717% | 28.164% | -17.408% |
| Ems-Chemie N | -0.730% | 2.850% | 16.700% | 28.957% | 49.324% | 55.088% | 56.738% |
| Givaudan S.A. | 2.200% | 1.328% | -5.953% | -2.102% | 5.782% | 44.597% | 45.006% |
| Solvay S.A. A | 0.300% | -0.378% | 0.076% | -4.003% | -3.441% | -74.413% | -76.696% |
